Had a wonderful time in Ann Arbor last week as this year’s McKesson Equity Series Speaker @ the University of Michigan College of Pharmacy sharing on the past, present, and future of this growing field.
Let’s work together to achieve #Pharmacoequity! 💊
Had a wonderful time in Ann Arbor last week as this year’s McKesson Equity Series Speaker @ the University of Michigan College of Pharmacy sharing on the past, present, and future of this growing field.
Let’s work together to achieve #Pharmacoequity! 💊
Always great to connect with mentors, role models, and friends at this meeting and to celebrate the new inductees into the Academy.
Always great to connect with mentors, role models, and friends at this meeting and to celebrate the new inductees into the Academy.
Yet, the future diffusion and equitable dissemination & implementation of these drugs is FAR less studied.
So many opportunities to advance #Pharmacoequity. 💊
Yet, the future diffusion and equitable dissemination & implementation of these drugs is FAR less studied.
So many opportunities to advance #Pharmacoequity. 💊
📝: www.sciencedirect.com/science/arti...
📝: www.sciencedirect.com/science/arti...
But not sure there is evidence to support that it’s “lagging knowledge” driving ⬇️ rates of treatment in low and middle income countries. 🤔
Hoping for more data ahead.
www.nejm.org/doi/full/10....
But not sure there is evidence to support that it’s “lagging knowledge” driving ⬇️ rates of treatment in low and middle income countries. 🤔
Hoping for more data ahead.
www.nejm.org/doi/full/10....
In 2023, lecanemab became the 1st disease-modifying 💊 for Alzheimer’s disease.
Led by 🌟 Frank Zhou, we found that early uptake of lecanemab still appears to be marked by racial, ethnic & socioeconomic disparities.
jamanetwork.com/journals/jam...
#Pharmacoequity
In 2023, lecanemab became the 1st disease-modifying 💊 for Alzheimer’s disease.
Led by 🌟 Frank Zhou, we found that early uptake of lecanemab still appears to be marked by racial, ethnic & socioeconomic disparities.
jamanetwork.com/journals/jam...
#Pharmacoequity
Led by @sudkrishnamurthy.bsky.social we found wide disparities in receipt of ERBB2-targeted 💊 for Medicare enrollees w. breast cancer, disparities that did narrow by 2019.
We need more research to identify strategies to improve cancer #Pharmacoequity.
jamanetwork.com/journals/jam...
Led by @sudkrishnamurthy.bsky.social we found wide disparities in receipt of ERBB2-targeted 💊 for Medicare enrollees w. breast cancer, disparities that did narrow by 2019.
We need more research to identify strategies to improve cancer #Pharmacoequity.
jamanetwork.com/journals/jam...
Grateful to Dr. Eileen Barrett for the nomination and to my Dad, the first and best internal medicine doctor I know. 🤎👨🏾⚕️
#FACP
cc @gradydoctor.bsky.social
Grateful to Dr. Eileen Barrett for the nomination and to my Dad, the first and best internal medicine doctor I know. 🤎👨🏾⚕️
#FACP
cc @gradydoctor.bsky.social
We need more than just talk right now to bring us closer to justice in health, but hoping to help inspire the future.
We need more than just talk right now to bring us closer to justice in health, but hoping to help inspire the future.
Her talk, “Antimicrobial Prescribing Disparities and the Pursuit of #Pharmacoequity” was data-filled and inspiring. ✨
Her talk, “Antimicrobial Prescribing Disparities and the Pursuit of #Pharmacoequity” was data-filled and inspiring. ✨
“The number of Black enrollees fell by 11.6%… Hispanic enrollees ⬇️ 10.8%… American Indian or Alaska Natives ⬇️ by 22.1%.”
www.statnews.com/2025/01/09/m...
“The number of Black enrollees fell by 11.6%… Hispanic enrollees ⬇️ 10.8%… American Indian or Alaska Natives ⬇️ by 22.1%.”
www.statnews.com/2025/01/09/m...
More data to seemingly debunk the “racial paradox” around AFib.
Ealier AFib detection for ALL patients may help to eliminate wide stroke disparities.
📝: www.sciencedirect.com/science/arti...
More data to seemingly debunk the “racial paradox” around AFib.
Ealier AFib detection for ALL patients may help to eliminate wide stroke disparities.
📝: www.sciencedirect.com/science/arti...
…This will help ensure that the needs of vulnerable patient populations are being considered & addressed.
academic.oup.com/ajhp/advance...
…This will help ensure that the needs of vulnerable patient populations are being considered & addressed.
academic.oup.com/ajhp/advance...
Enjoyed being back home in NY.🗽
#Pharmacoequity
Enjoyed being back home in NY.🗽
#Pharmacoequity
Really exciting to see this concept expanding!
secure.jbs.elsevierhealth.com/action/getSh...
Really exciting to see this concept expanding!
secure.jbs.elsevierhealth.com/action/getSh...
Excited for #AHA24! Looking forward to sharing our latest #AFib work and presenting on #Pharmacoequity with an all-⭐️ team @ the ABC Symposium.
But mostly ready to reconnect with friends & colleagues in the Chi. 💨
See y’all soon. 👊🏾
Excited for #AHA24! Looking forward to sharing our latest #AFib work and presenting on #Pharmacoequity with an all-⭐️ team @ the ABC Symposium.
But mostly ready to reconnect with friends & colleagues in the Chi. 💨
See y’all soon. 👊🏾